Results 151 to 160 of about 11,945 (263)

The influence of a dicationic surfactant on the aggregation process of the IVAGVN peptide derived from the human cystatin C sequence (56–61)

open access: gold
Julia Ludwiczak   +7 more
openalex   +2 more sources

Bayesian Analysis of Frailty Risk Factors in Chronic Kidney Disease: A Nationwide Cross‐Sectional Survey

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Frailty in chronic kidney disease (CKD) patients is associated with increased risk of adverse health outcomes. Understanding the contributing factors to frailty in this population is crucial for developing targeted interventions and improving patient care.
Jiao Wang   +6 more
wiley   +1 more source

Physiologically Based Pharmacokinetic Modeling of Caffeine in Preterm Neonates: Influence of Renal Function and Impairment on Dosing

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Currently, the same weight‐based caffeine citrate dosing regimen is applied to all neonates. However, due to differences in growth trajectories by gestational age (GA) and altered caffeine elimination in neonates with renal injury, optimal dosing regimens may differ. In this study, we refined the existing physiologically based pharmacokinetic (
Nolan Thomas   +2 more
wiley   +1 more source

Effect of sugarcane cystatin CaneCPI-5 on osteogenic differentiation of human dental pulp cells. [PDF]

open access: yesBraz Dent J
Cassiano AFB   +4 more
europepmc   +1 more source

Cystatin C and Sudden Cardiac Death Risk in the Elderly

open access: green, 2010
Rajat Deo   +9 more
openalex   +2 more sources

Nutritional Management in Severe Methylmalonic and Propionic Acidemias: How Much Medical Food Is Too Much?

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 1, January 2026.
ABSTRACT Methylmalonic acidemia (MMA) and propionic acidemia (PA) are inherited metabolic disorders affecting valine and isoleucine catabolism. Long‐term therapy mainly involves dietary protein restriction. An amino acid mixture (AAM, medical food) free of the precursor amino acids is frequently used, especially when protein intake does not reach World
Diane Margoses   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy